Julia Spiegelberg

Dr. Julia Spiegelberg


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2022 in Cancers
Verified
Journal Article
Open access
PDF file
JSJulia Spiegelberg
Julia Spiegelberg
TITanja Iken
Tanja Iken
MDMarkus K Diener
Markus K Diener
SFStefan Fichtner-Feigl
Stefan Fichtner-Feigl
Hepatocellular and cholangiocellular carcinoma are fatal primary hepatic tumors demanding extensive liver resection. Liver surgery is technically challenging due to the complex liver anatomy, with an intensive and variant vascular and biliary system. Therefore, major hepatectomies in particular are often performed by open resection and minor hepatectomies are often performed minimally invasively. More centers have adopted robotic-assisted surgery, intending to improve the laparoscopic surgical limits, as it offers some technical benefits such as seven degrees of freedom and 3D visualization. The da Vinci® Surgical System has dominated the surgical robot market since 2000 and has shown surgical feasibility, but there is still much controversy about its economic benefits and real benefits for the patient over the gold standard. The currently available retrospective case studies are difficult to compare, and larger, prospective studies and randomized trials are still urgently missing. Therefore, here we summarize the technical, surgical, and economic outcomes of robotic versus open and laparoscopic hepatectomies for primary liver tumors found in the latest literature reviews and meta-analyses. We conclude that complex robotic liver resections (RLR) are safe and feasible after the steep learning curve of the surgical team has plateaued. The financial burden is lower in high volume centers and is expected to decrease soon as new surgical systems will enter the market.

11 August 2022 in BMC Surgery
Verified
Journal Article
Open access
PDF file
JSJulia Spiegelberg
Julia Spiegelberg
ALAnn-Kathrin Lederer
Ann-Kathrin Lederer
SCSibylla Claus
Sibylla Claus
MRMira Runkel
Mira Runkel
SUStefan Utzolino
Stefan Utzolino
LKLampros Kousoulas
Lampros Kousoulas
Background: Etiology of hyperlactatemia in ICU patients is heterogeneous—septic, cardiogenic or hemorrhagic shock seem to be predominant reasons. Multiple studies show hyperlactatemia as an independent predictor for ICU mortality. Only limited data exists about the etiology of hyperlactatemia and lactate clearance and their influence on mortality. The goal of this single-center retrospective study, was to evaluate the effect of severe hyperlactatemia and reduced lactate clearance rate on the outcome of unselected ICU surgical patients. Methods: Overall, 239 surgical patients with severe hyperlactatemia (> 10 mmol/L) who were treated in the surgical ICU at the University Medical Center Freiburg between June 2011 and August 2017, were included in this study. The cause of the hyperlactatemia as well as the postoperative course and the patient morbidity and mortality were retrospectively analyzed. Lactate clearance was calculated by comparing lactate level 12 h after first measurement of > 10 mmol/L. Results: The overall mortality rate in our cohort was 82.4%. Severe hyperlactatemia was associated with death in the ICU (p < 0.001). The main etiologic factor was sepsis (51.9%), followed by mesenteric ischemia (15.1%), hemorrhagic shock (13.8%) and liver failure (9.6%). Higher lactate levels at ICU admission were associated with increased mortality (p < 0.001). Lactate clearance after 12 h was found to predict ICU mortality (ANOVA p < 0.001) with an overall clearance of under 50% within 12 h. The median percentage of clearance was 60.3% within 12 h for the survivor and 29.1% for the non-survivor group (p < 0.001). Conclusion: Lactate levels appropriately reflect disease severity and are associated with short-term mortality in critically ill patients. The main etiologic factor for surgical patients is sepsis. When elevated lactate levels persist more than 12 h, survival chances are low and the benefit of continued maximum therapy should be evaluated.

20 May 2022 in Research Square
Verified
Preprint
Open access
PDF file
JSJulia Spiegelberg
Julia Spiegelberg
ALAnn-Kathrin Lederer
Ann-Kathrin Lederer
SCSibylla Claus
Sibylla Claus
MRMira Runkel
Mira Runkel
SUStefan Utzolino
Stefan Utzolino
LKLampros Kousoulas
Lampros Kousoulas
BACKGROUNDEtiology of hyperlactatemia in ICU patients is heterogeneous - septic, cardiogenic or hemorrhagic shock seem to be predominant reasons. Multiple studies show hyperlactatemia as an independent predictor for ICU mortality. Only limited data exists about the etiology of hyperlactatemia and lactate clearance and their influence on mortality. The goal of this single-center retrospective study, was to evaluate the effect of severe hyperlactatemia and reduced lactate clearance rate on the outcome of unselected ICU surgical patients. METHODSOverall, 239 surgical patients with severe hyperlactatemia (>10 mmol/L) who were treated in the surgical ICU at the University Medical Center Freiburg between June 2011 and August 2017, were included in this study. The cause of the hyperlactatemia as well as the postoperative course and the patient morbidity and mortality were retrospectively analyzed. Lactate clearance was calculated by comparing lactate level 12h after first measurement of >10mmol/L.RESULTSThe overall mortality rate in our cohort was 82.4%. Severe hyperlactatemia was associated with death in the ICU (p<0.001). The main etiologic factor was sepsis (51.9%), followed by mesenteric ischemia (15.1%), hemorrhagic shock (13.8%) and liver failure (9.6%). Higher lactate levels at ICU admission were associated with increased mortality (p< 0.001). Lactate clearance after 12h was found to predict ICU mortality (ANOVA p<0.001) with an overall clearance of under 50% within 12h. The median percentage of clearance was 60.3% within 12h for the survivor and 29.1% for the non-survivor group (p < 0.001). CONCLUSIONLactate levels appropriately reflect disease severity and are associated with short-term mortality in critically ill patients. The main etiologic factor for surgical patients is sepsis. When elevated lactate levels persist more than 12h, survival chances are low and the benefit of continued maximum therapy should be evaluated.